Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-08-16

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and 5'-amino-5'-deoxyadenosine

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with 5'-amino-5'-deoxyadenosine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coyle, TS; Kaplan, GB1

Other Studies

1 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and 5'-amino-5'-deoxyadenosine

ArticleYear
Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation.
    European journal of pharmacology, 1998, Nov-27, Volume: 362, Issue:1

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine Kinase; Animals; Body Weight; Caffeine; Deoxyadenosines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Mice; Morphine; Receptors, Purinergic P1; Substance Withdrawal Syndrome

1998